Shun Nakagama

Rivaroxaban, a Direct Oral Factor Xa Inhibitor, Attenuates Atherosclerosis by Alleviating Factor Xa–PAR2-Mediated Autophagy Suppression

Yusuke Ito, Yasuhiro Maejima, Shun Nakagama et al. · JACC Basic to Translational Science · 2021 · 34 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Neutrophil extracellular traps-mediated Beclin-1 suppression aggravates atherosclerosis by inhibiting macrophage autophagy

Masataka Sano, Yasuhiro Maejima, Shun Nakagama et al. · Frontiers in Cell and Developmental Biology · 2022 · 30 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Urinary Liver-Type Fatty Acid-Binding Protein Level as a Predictive Biomarker of Acute Kidney Injury in Patients with Acute Decompensated Heart Failure

Keiichi Hishikari, Hiroyuki Hikita, Shun Nakamura et al. · Cardiorenal Medicine · 2017 · 28 citations · Full text

Medicine, Cardiology, Nephrology +17

Process for immune defect and chromosomal translocation during early thymocyte development lacking ATM

Takeshi Isoda, Masatoshi Takagi, Jinhua Piao et al. · Blood · 2012 · 27 citations · Full text

Life Sciences, Genetics, Immunology +16

Usefulness of Lipoprotein(a) for Predicting Clinical Outcomes After Endovascular Therapy for Aortoiliac Atherosclerotic Lesions

Keiichi Hishikari, Hiroyuki Hikita, Shun Nakamura et al. · Journal of Endovascular Therapy · 2017 · 25 citations

Medicine, Cardiology, Surgery +15